Also trades as: 005250.KS (KSC) · $vol 2M
005257.KS KSC
GC Corp.
1W: -1.8%
1M: +4.7%
3M: -2.6%
YTD: -26.0%
1Y: -40.8%
3Y: -34.0%
5Y: -77.1%
₩18,350.00 ($13.68)
+0.00 (+0.00%)
Weekly Expected Move ±4.1%
₩16834
₩17592
₩18350
₩19108
₩19866
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Smart Money Score
No convergence signal
Key Statistics
Market Cap₩551.5B ($411.2M)
52W Range13700-31700
Volume44
Avg Volume2,242
Beta0.56
Dividend₩300.00
Analyst Ratings
No analyst coverage
Company Info
CEOHuh Eun-chul
Employees151
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date1996-01-30
Websitegcbiopharma.com
107, Ihyeon-ro 30beon-gil, Giheung-gu
Yongin-Si, GY 16924
KR
Yongin-Si, GY 16924
KR
82 3 1260 9300
About GC Corp.
GC Corp. is engaged in the manufacture of pharmaceutical products and oversees the establishment and coordination of business strategies for Green Cross subsidiaries, including business launch and investment portfolio management. The company's prescription drug portfolio includes blood derivatives, cerebrovascular disease treatments, fibrinolytic agents, vaccines, hunter syndrome therapies, herbal medicines, and recombinant products. It also offers over-the-counter drugs such as skin disease treatments and topical non-steroidal anti-inflammatories. GC Corp. was founded on October 5, 1967, and is headquartered in Yongin-si, South Korea.
Latest News
No recent news
Recent Insider Trades
No insider trades found